HCPCS Level II code C1760 denotes an implantable or insertable vascular closure device used to achieve hemostasis after vascular access procedures. These devices are widely used in cardiovascular and interventional procedures to reduce time to hemostasis and facilitate patient recovery, affecting hospital and ambulatory surgical billing nationally. Understanding coding and coverage for C1760 is important for accurate device billing and inventory control.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of national payer coverage patterns, common billing modifiers, and the typical clinical contexts in which C1760 is reported. The publication summarises service settings, common use-cases in vascular and interventional procedures, and where to look for payer-specific policy language.

This summary provides: device description and clinical context; typical sites of service and procedural settings; payer landscape and coverage considerations; and references for further coding and policy review. Data not available in the input is noted where applicable. The goal is to inform coding professionals, billing staff, and health policy analysts about the role and billing context of HCPCS Level II code C1760 at a national level.